Retour
Fourchette du Jour
9,11 €
9,62 €
Fourchette 52 Semaines
8,70 €
22,96 €
Volume
1 053 748
Moyenne 50J / 200J
11,06 €
/
12,79 €
Clôture Précédente
8,94 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -1,4 | 0,4 |
| P/B | 0,7 | 2,9 |
| ROE % | -39,9 | 3,7 |
| Net Margin % | -31,6 | 3,9 |
| Rev Growth 5Y % | 1,5 | 10,0 |
| D/E | 2,0 | 0,2 |
Objectif de Cours des Analystes
Hold
15,00 €
+59.1%
P/E Prévisionnel
4,0
BPA Prévisionnel
2,35 €
Croissance BPA (est.)
+0,0%
CA Est.
1,7 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2028 |
2,74 €
2,71 € – 2,76 €
|
1,8 B | 1 |
| FY2027 |
2,55 €
2,49 € – 2,62 €
|
1,7 B | 5 |
| FY2026 |
2,35 €
2,30 € – 2,37 €
|
1,7 B | 6 |
Insider Trading Activity
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 11, 2026 |
Hutchinson Michael Damon
EVP, Chief Legal Officer & Sec
|
grant | 70 305 | — | — |
| Mar 11, 2026 |
Knight Lea Daniels
EVP & Chief Financial Officer
|
other | 8 089 | 9,61 € | 77 735 € |
| Mar 11, 2026 |
Knight Lea Daniels
EVP & Chief Financial Officer
|
grant | 111 179 | — | — |
| Mar 11, 2026 |
DAVIS ROBERT T. JR.
EVP & President, TT
|
other | 8 487 | 9,61 € | 81 560 € |
| Mar 11, 2026 |
DAVIS ROBERT T. JR.
EVP & President, TT
|
grant | 43 350 | — | — |
| Mar 11, 2026 |
McBreen Michael J.
EVP & President, CSS
|
other | 7 247 | 9,61 € | 69 644 € |
| Mar 11, 2026 |
McBreen Michael J.
EVP & President, CSS
|
grant | 92 108 | — | — |
| Mar 10, 2026 |
DAVIS ROBERT T. JR.
EVP & President, TT
|
other | 687 | 9,55 € | 6 561 € |
| Mar 10, 2026 |
McBreen Michael J.
EVP & President, CSS
|
other | 2 354 | 9,55 € | 22 481 € |
| Feb 2, 2026 |
Hutchinson Michael Damon
EVP, Chief Legal Officer & Sec
|
grant | 89 606 | — | — |
| Nov 5, 2025 |
GRAVES JEFFREY A
Director
|
buy | 9 000 | 11,35 € | 102 150 € |
| Oct 12, 2025 |
Singh Harvinder
EVP & PRESIDENT, INTERNATIONAL
|
other | 27 211 | — | — |
| Jul 3, 2025 |
Mosebrook Jeffrey
SVP, Fin & Princ Acct Officer
|
other | 3 345 | 13,49 € | 45 124 € |
| Jul 3, 2025 |
Knight Lea Daniels
EVP & Chief Financial Officer
|
other | 2 561 | 13,49 € | 34 548 € |
| Jul 1, 2025 |
Mosebrook Jeffrey
SVP, Fin & Princ Acct Officer
|
other | 937 | 13,25 € | 12 415 € |
| May 9, 2025 |
BRADLEY KEITH
Director
|
other | 392 | 12,25 € | 4 802 € |
| May 9, 2025 |
BRADLEY KEITH
Director
|
grant | 19 592 | — | — |
| May 9, 2025 |
HILL BARBARA B
Director
|
grant | 26 531 | — | — |
| May 9, 2025 |
Clay Shaundra
Director
|
grant | 19 592 | — | — |
| May 9, 2025 |
Lo Renee Wonlai
Director
|
grant | 19 592 | — | — |
Points Clés
Revenue grew 1,47% annually over 5 years — modest growth
Negative free cash flow of -31,05M
Capital efficient — spends only 4,98% of revenue on capex
ROIC of 1,67% — low return on invested capital
Interest coverage of 0,79× — tight debt servicing
Croissance
Revenue Growth (5Y)
1,47%
Revenue (1Y)1,53%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-39,90%
ROIC1,67%
Net Margin-31,58%
Op. Margin4,18%
Sécurité
Debt / Equity
1,95
Current Ratio2,54
Interest Coverage0,79
Valorisation
P/E Ratio
-1,42
P/B Ratio0,70
EV/EBITDA37,08
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1,53% | Revenue Growth (3Y) | 2,99% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 1,47% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,64B | Net Income (TTM) | -516,47M |
| ROE | -39,90% | ROA | -14,34% |
| Gross Margin | 51,69% | Operating Margin | 4,18% |
| Net Margin | -31,58% | Free Cash Flow (TTM) | -31,05M |
| ROIC | 1,67% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,95 | Current Ratio | 2,54 |
| Interest Coverage | 0,79 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -1,42 | P/B Ratio | 0,70 |
| P/S Ratio | 0,45 | PEG Ratio | 0,00 |
| EV/EBITDA | 37,08 | Dividend Yield | 0,00% |
| Market Cap | 734,95M | Enterprise Value | 2,53B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,64B | 1,61B | 1,54B | 1,56B | 1,54B |
| Net Income | -516,47M | -6,94M | 67,74M | 180,55M | 169,08M |
| EPS (Diluted) | -6,73 | -0,09 | 0,84 | 2,16 | 1,98 |
| Gross Profit | 845,23M | 882,06M | 884,74M | 970,31M | 944,64M |
| Operating Income | 68,32M | 28,41M | 111,53M | 238,92M | 197,23M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3,60B | 4,04B | 3,78B | 3,89B | 3,78B |
| Total Liabilities | 2,56B | 2,49B | 2,19B | 2,09B | 2,10B |
| Shareholders' Equity | 1,04B | 1,55B | 1,59B | 1,80B | 1,68B |
| Total Debt | 2,03B | 1,98B | 1,68B | 1,63B | 1,67B |
| Cash & Equivalents | 235,05M | 246,38M | 276,40M | 456,66M | 513,45M |
| Current Assets | 1,16B | 1,08B | 1,06B | 1,16B | 1,15B |
| Current Liabilities | 455,98M | 922,13M | 306,98M | 320,91M | 340,02M |